Fig. 3From: One year monitoring of SARS-CoV-2 prevalence in a German cohort of patients with cystic fibrosisNo changes in lung function parameters prior to (t-1) and with/after SARS-CoV-2 infection (t). Measurement in patients > 6 years. FEV1 forced expiratory volume in one second, FVC forced vital capacity, MEF25 maximum expiratory flow at 25% of FVC, MEF75-25 maximum midexpiratory flow between 75 and 25% of FVCBack to article page